Unterhalt M - Search Results

1

Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).

Scheubeck G, Jiang L, Hermine O, Kluin-Nelemans HC, Schmidt C, Unterhalt M, Rosenwald A, Klapper W, Evangelista A, Ladetto M, Jerkeman M, Ferrero S, Dreyling M, Hoster E. Scheubeck G, et al. Among authors: unterhalt m. Leukemia. 2023 Sep;37(9):1887-1894. doi: 10.1038/s41375-023-01977-y. Epub 2023 Jul 26. Leukemia. 2023. PMID: 37495776 Free PMC article.

2

Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies.

Binder L, Schiel X, Binder C, Menke CF, Schüttrumpf S, Armstrong VW, Unterhalt M, Erichsen N, Hiddemann W, Oellerich M. Binder L, et al. Among authors: unterhalt m. Clin Chem. 1998 Feb;44(2):408-14. Clin Chem. 1998. PMID: 9474052

3

Recent advances in antigen-targeted therapy in non-Hodgkin's lymphoma.

Feuring-Buske M, Buske C, Unterhalt M, Hiddemann W. Feuring-Buske M, et al. Among authors: unterhalt m. Ann Hematol. 2000 Apr;79(4):167-74. doi: 10.1007/s002770050575. Ann Hematol. 2000. PMID: 10834503 Review.

4

Detection and determination of the major metabolites of [3H]cytosine arabinoside by high-performance liquid chromatography.

Braess J, Pförtner J, Kaufmann CC, Ramsauer B, Unterhalt M, Hiddemann W, Schleyer E. Braess J, et al. Among authors: unterhalt m. J Chromatogr B Biomed Appl. 1996 Feb 9;676(1):131-40. doi: 10.1016/0378-4347(95)00372-x. J Chromatogr B Biomed Appl. 1996. PMID: 8852053

5

Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial.

Witzens-Harig M, Hensel M, Unterhalt M, Herfarth K. Witzens-Harig M, et al. Among authors: unterhalt m. BMC Cancer. 2011 Feb 26;11:87. doi: 10.1186/1471-2407-11-87. BMC Cancer. 2011. PMID: 21352561 Free PMC article. Clinical Trial.

6

Column-switching solid-phase trace-enrichment high-performance liquid chromatographic method for measurement of buprenorphine and norbuprenorphine in human plasma and urine by electrochemical detection.

Schleyer E, Lohmann R, Rolf C, Gralow A, Kaufmann CC, Unterhalt M, Hiddemann W. Schleyer E, et al. Among authors: unterhalt m. J Chromatogr. 1993 May 5;614(2):275-83. doi: 10.1016/0378-4347(93)80319-y. J Chromatogr. 1993. PMID: 8314940

7

[Current status of therapy of follicular germ center lymphoma and mantel cell lymphoma].

Hiddemann W, Unterhalt M, Sack H. Hiddemann W, et al. Among authors: unterhalt m. Internist (Berl). 1997 Feb;38(2):122-34. Internist (Berl). 1997. PMID: 9157057 Review. German. No abstract available.

8

IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group.

Feuring-Buske M, Kneba M, Unterhalt M, Engert A, Gramatzki M, Hiller E, Trümper L, Brugger W, Ostermann H, Atzpodien J, Hallek M, Aulitzky E, Hiddemann W. Feuring-Buske M, et al. Among authors: unterhalt m. Ann Hematol. 2000 Sep;79(9):493-500. doi: 10.1007/s002770000163. Ann Hematol. 2000. PMID: 11043420 Clinical Trial.

9

[Therapy of low-grade non-Hodgkin lymphomas].

Hiddemann W, Unterhalt M, Wörmann B. Hiddemann W, et al. Among authors: unterhalt m. Praxis (Bern 1994). 1996 Mar 19;85(12):357-63. Praxis (Bern 1994). 1996. PMID: 8643898 Review. German.

10

Rituximab therapy for indolent non-Hodgkin's lymphoma.

Hagenbeek A, Czuczman MS, Ghielmini M, Herold M, Kimby E, Solal-Céligny P, Unterhalt M. Hagenbeek A, et al. Among authors: unterhalt m. Anticancer Drugs. 2002 Nov;13 Suppl 2:S11-7. Anticancer Drugs. 2002. PMID: 12710586 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page